Lee's Pharmaceutical Holdings Limited (HKG:0950)

HKG:0950 Revenue

Lee's Pharmaceutical Holdings had revenue of 796.57M HKD in the half year ending June 30, 2026, with 21.00% growth. This brings the company's total for the last twelve months to 1.54B, up 7.05% year-over-year. In the year 2025, Lee's Pharmaceutical Holdings had annual revenue of 1.44B with 2.57% growth. That makes Lee's Pharmaceutical Holdings the 17,632nd largest company in the world by revenue and 1,018th in Hong Kong.

• Revenue (ttm): 1.54B
• Revenue Growth: +7.05%
• P/S Ratio: 0.39
• Revenue / Employee: 1.35M
• Employees: 1,137
• Market Cap: 606.50M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Proprietary and Generic Products 871.65M 60.7%
• Licensed-In Products 564.34M 39.3%

Fiscal year ended Dec 31, 2025 See the full HKG:0950 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.44B	36.01M	2.57%
Dec 31, 2024	1.40B	346.94M	32.95%
Dec 31, 2023	1.05B	-180.11M	-14.61%
Dec 31, 2022	1.23B	-33.01M	-2.61%
Dec 31, 2021	1.27B	49.44M	4.06%

Data Source: S&P Global Market Intelligence Last updated: Sep 22, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 31, 2026

Data Sources Report a data error